Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.
Journal: The European respiratory journal
Published: September 04, 2025
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 study.
Journal: The European respiratory journal
Published: September 04, 2025
Revealing Dentin Multiscale Structures Using High-Resolution Transmission Electron Microscopy.
Journal: Journal of dental research
Published: September 01, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosis.
Journal: Contemporary clinical trials
Published: March 03, 2025
Study protocol: A comparison of mobile and clinic-based spirometry for capturing the treatment effect in moderate asthma.
Journal: Clinical and translational science
Published: May 26, 2023
Response to "Wearable Remote Monitoring and COVID-19".
Journal: Clinical and translational science
Published: October 02, 2021
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial.
Journal: BMJ open respiratory research
Published: July 20, 2021
Closer to the patient means better decisions: wearable remote monitoring of patients with COVID-19 lung disease.
Journal: Clinical and translational science
Published: March 24, 2021
Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.
Journal: Journal of clinical pharmacology
Published: June 18, 2020
Adverse events associated with weight-based, high-dose montelukast exposures in children.
Journal: Clinical toxicology (Philadelphia, Pa.)
Published: May 07, 2019
Characterization of deproteinized dentin for its use in bone tissue engineering.
Journal: Computer methods in biomechanics and biomedical engineering
Published: November 02, 2017
Adverse events are rare after single-dose montelukast exposures in children.
Journal: Clinical toxicology (Philadelphia, Pa.)
Published: June 23, 2017
Last Updated: 09/26/2026